GLP3 RETA

GLP-3 Reta is a retatrutide-based peptide studied for its interaction with multiple incretin-related receptors involved in metabolic signaling pathways [1,2].

This peptide is for research purposes only. Not for human consumption.

This product is currently out of stock and unavailable.

SKU: N/A Category:

Description

Multi-Receptor Signaling

Retatrutide analogs are examined for simultaneous interaction with GLP-1, GIP, and glucagon receptors [1]. Research models focus on receptor cross-activation and coordinated pathway behavior.

Metabolic Regulation Studies

Studies explore how multi-agonist signaling influences energy balance, glucose regulation markers, and lipid metabolism pathways [2].

Advanced Peptide Design

GLP-3 constructs are used to assess how single peptides influence multiple endocrine signaling networks in comparative pathway research [1].

Key Specs

  • Peptide class: multi-incretin analog
  • Research context: metabolic and endocrine signaling
  • References: PubMed [1,2]

Referenced Citations

  1. PubMed, Retatrutide and multi-agonist signaling: https://pubmed.ncbi.nlm.nih.gov/36419021/
  2. PubMed, Incretin receptor cross-talk: https://pubmed.ncbi.nlm.nih.gov/32728220/

Additional information

Size

5MG, 10MG, 15MG

Reviews

There are no reviews yet.

Be the first to review “GLP3 RETA”

Multi-Receptor Signaling

Retatrutide analogs are examined for simultaneous interaction with GLP-1, GIP, and glucagon receptors [1]. Research models focus on receptor cross-activation and coordinated pathway behavior.

Metabolic Regulation Studies

Studies explore how multi-agonist signaling influences energy balance, glucose regulation markers, and lipid metabolism pathways [2].

Advanced Peptide Design

GLP-3 constructs are used to assess how single peptides influence multiple endocrine signaling networks in comparative pathway research [1].

Key Specs

  • Peptide class: multi-incretin analog
  • Research context: metabolic and endocrine signaling
  • References: PubMed [1,2]

Referenced Citations

  1. PubMed, Retatrutide and multi-agonist signaling: https://pubmed.ncbi.nlm.nih.gov/36419021/
  2. PubMed, Incretin receptor cross-talk: https://pubmed.ncbi.nlm.nih.gov/32728220/
0
    Shopping Cart
    Your cart is emptyReturn to Shop